22.6 C
New York
Saturday, June 13, 2026

Tag: submission

newssourceFORcompanyinformationcontent1marketreleases

InventHelp Inventor Develops Improved Cordless Pipe Wrench (FJK-603)

PITTSBURGH, June 8, 2026 /PRNewswire/ -- "As a plumber, I needed a better way to increase torque when gripping and rotating pipes into position,"...

InventHelp Inventor Develops Modified Tire Thumper for Truck Drivers (FDD-114)

PITTSBURGH, June 8, 2026 /PRNewswire/ -- "As a truck driver, I thought there could be a more convenient tool for checking tire air pressure,"...

InventHelp Inventor Develops New Itch Relief Product (CNH-6076)

PITTSBURGH, June 8, 2026 /PRNewswire/ -- "I thought there should be a convenient way to apply heat to an itch to activate transient receptor...

InventHelp Inventor Develops Protective Barrier for Packages in Delivery Trucks (CNH-6045)

PITTSBURGH, June 8, 2026 /PRNewswire/ -- "I wanted to create a physical barrier to keep packages intact on their respective shelves within a delivery...

Shell plc Commences Registered Exchange Offers for Notes Issued in Connection with Prior Private Exchange Offer by Shell Finance US Inc.

Press Release

Annual Report for the year ended 31 January 2026 and Notice of Meeting

OCTOPUS APOLLO VCT PLC

Foresee’s Oral ALDH2 Activator, Mirivadelgat to Enter Clinical Testing in Parkinson’s Disease in the SLEIPNIR Phase 2a Platform Trial

TAIPEI, June 8, 2026 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced today that Foresee's oral ALDH2 activator, mirivadelgat, has been selected to enter clinical testing in...

Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®

REYKJAVIK, Iceland, June 08, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for AVT16, a proposed interchangeable biosimilar to Entyvio® (vedolizumab) lyophilized vial for intravenous administration.

The 34th Eye Level Literary Awards Opens Global Literary Submissions

SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Daekyo Culture Foundation and the World Youth Culture Foundation announce the opening of submissions for the 34th...

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

Diabetic ketoacidosis (DKA) can develop quickly and is not always easy to detect earlyKetone monitoring is not yet routine in diabetes care, which may...

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors it Has Filed a Complaint to Recover Losses Suffered by Purchasers of Verra Mobility Corporation Common...

NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

Centurion Acquisition Corp. Announces Postponement of Shareholders’ Meeting to Friday, June 12, 2026, and Extension of Redemption Request Deadline

NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- Centurion Acquisition Corp., a Cayman Islands exempted company, (“Centurion” or the “Company”) (Nasdaq: ALF) today announced that it intends to postpone its previously announced Extraordinary General Meeting of shareholders (the “Meeting”) from June 9, 2026, at 11:00 a.m. Eastern Time, to June 12, 2026 at 11:00 a.m. Eastern Time to allow Centurion additional time to engage with shareholders.

Avaana Launches National Registration Readiness Program to Help Disability Providers Meet New Mandatory NDIS Compliance Requirements

New end-to-end compliance initiative supports providers preparing for the Federal Government’s expanded NDIS registration reforms ahead of the July 2027 Mandatory Registration deadline

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSubmission

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers